Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep contrastive learning framework identifies cell-type-specific drug targets in Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

CHCHD10 Mitigates Alzheimer's Disease-Related Phenotypes in Association With Epigenetic Remodeling in Directly Reprogrammed Neurons.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells.

Nature cancer·2026
Same author

The gut-brain axis in Alzheimer's disease: early detection, microbial metabolites, mechanisms, and therapeutic opportunities.

Frontiers in molecular biosciences·2026
Same author

Targeting EP2/EP4-driven expansion of suppressive VSIG4<sup>high</sup> macrophages overcomes immunotherapy resistance in colorectal cancer.

Cell reports·2026
Same author

Alzheimer's disease drug development pipeline: 2026.

Alzheimer's & dementia (New York, N. Y.)·2026
Same journal

Social Drivers of Health in the Electronic Health Record.

Annual review of biomedical data science·2026
Same journal

Artificial Intelligence in Image-Based Cardiovascular Disease Analysis.

Annual review of biomedical data science·2026
Same journal

Reclaiming Data, Restoring Health: The Indigenous Biomedical Data Science Renaissance.

Annual review of biomedical data science·2026
Same journal

Modeling the Language of Codons with Artificial Intelligence.

Annual review of biomedical data science·2026
Same journal

Exploring Genetic Variations Associated with the Immune Response in Underrepresented Populations.

Annual review of biomedical data science·2026
Same journal

Sex and the Genome: Divergent Genetic Architecture Across the Human Lifespan.

Annual review of biomedical data science·2026
See all related articles

Related Experiment Video

Updated: Sep 25, 2025

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

6.4K

Open Structural Data in Precision Medicine.

Ruth Nussinov1,2, Hyunbum Jang1, Guy Nir3

  • 1Computational Structural Biology Section, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, National Cancer Institute, Frederick, Maryland, USA;

Annual Review of Biomedical Data Science
|April 28, 2022
PubMed
Summary
This summary is machine-generated.

High-resolution protein structures are key for precision medicine, aiding drug discovery and understanding patient mutations. Advances in technology and computation are making this data more accessible to transform personalized pharmacology.

Keywords:
AIKRascancerchromatin accessibilitydrug resistancefree-energy landscapemachine learningnetwork medicinesignalingtargeted therapy

More Related Videos

Mass Spectrometry-Based Proteomics Analyses Using the OpenProt Database to Unveil Novel Proteins Translated from Non-Canonical Open Reading Frames
07:38

Mass Spectrometry-Based Proteomics Analyses Using the OpenProt Database to Unveil Novel Proteins Translated from Non-Canonical Open Reading Frames

Published on: April 11, 2019

12.9K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.2K

Related Experiment Videos

Last Updated: Sep 25, 2025

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

6.4K
Mass Spectrometry-Based Proteomics Analyses Using the OpenProt Database to Unveil Novel Proteins Translated from Non-Canonical Open Reading Frames
07:38

Mass Spectrometry-Based Proteomics Analyses Using the OpenProt Database to Unveil Novel Proteins Translated from Non-Canonical Open Reading Frames

Published on: April 11, 2019

12.9K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.2K

Area of Science:

  • Structural Biology
  • Computational Biology
  • Genomics

Background:

  • Three-dimensional protein structural data is essential for precision medicine.
  • Understanding protein mutations aids in targeted drug discovery and patient treatment.
  • Limited availability and high costs of structural data hinder its widespread clinical use.

Purpose of the Study:

  • To review the importance of high-resolution protein and genome data in precision medicine.
  • To discuss the methods and applications of utilizing structural and dynamical data.
  • To highlight the transformative potential of accessible structural data in personalized pharmacology.

Main Methods:

  • Review of experimental high-resolution structural determination techniques.
  • Analysis of computational modeling algorithms, including molecular dynamics simulations.
  • Integration of structural data with big data analytics.

Main Results:

  • Technological advancements are rapidly increasing the generation of structural data.
  • Computational power, including graphics processing units, is enhancing modeling capabilities.
  • Accessible, freely available structural and dynamical data can revolutionize personalized medicine.

Conclusions:

  • High-resolution structural data is crucial for advancing precision medicine.
  • The synergy of experimental and computational approaches is vital for data generation and interpretation.
  • Leveraging accessible structural and genomic data holds immense promise for personalized pharmacology and improved patient outcomes.